Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-20

Clinical Trial Update: Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients [Phase 3]

View source ↗

Summary

A completed Phase 3 study evaluating FS 4 IU VH S/D (fibrin sealant with 4 IU/mL thrombin, vapor heated, solvent/detergent treated) to help adhere split-thickne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FS 4 IU VH S/D (Fibrin sealant with thrombin (4 IU/mL), vapor heated, solvent/detergent treated)

Snippet

Sponsor: Baxter Healthcare Corporation | Conditions: Deep Partial or Full Thickness Wounds | Phase 3 | Status: COMPLETED